SCHEMBL21776644

SCHEMBL21776644

CCCCCc1oc(=O)cc(OC)c1C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.42
PPARA Q07869 2/20 0.39
PPARG P37231 1/20 0.39
CNR2 P34972 1/20 0.39
ALOX5 P09917 7/20 0.39
KDM4E B2RXH2 1/20 0.38
MGLL Q99685 1/20 0.38
MAPT P10636 1/20 0.37
NPC1 O15118 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTGS2 P35354 3/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21776487 0.74 HCAR2 (0.42) ALOX5KDM4EMAPTMAPK1SMN1; SMN2
SCHEMBL28487003 0.72 PTGES (0.56) PTPN1PPARAPPARGALOX5KDM4E
SCHEMBL2859810 0.70 ALOX5 (0.40) PTPN1PPARAPPARGALOX5MGLL
SCHEMBL11107777 0.69 THRB (0.35) PPARAPPARGCNR2MAPTNPC1
SCHEMBL21776486 0.67 PDE3B (0.42) KDM4EMAPTMAPK1ALDH1A1CYP3A4
SCHEMBL16666462 0.67 ALOX5 (0.36) ALOX5ALDH1A1
SCHEMBL12704738 0.67 MCL1 (0.40) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL8329252 0.67 SMPD1 (0.50) CNR2MAPT
SCHEMBL2945568 0.67 PPARA (0.77) PPARAPPARGALOX5PTGS2
SCHEMBL28598339 0.67 MAOA (0.42) PPARAPPARGCNR2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020041851-A2 PHARMACEUTICAL COMPOSITION, PROCESS FOR OBTAINING AND USING SECONDARY METABOLITES PRODUCED BY THE FUNGUS EXSEROHILUM ROSTRATUM IN CELL REGENERATION INSTITUTO BUTANTAN (BR) 2020-03-05 WO disclosed